Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J. Clin. 71, 209–249 (2021).

Article  Google Scholar 

Tomasetti, C. & Vogelstein, B. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78–81 (2015). Cancer etiology.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Whiteman, D. C. & Wilson, L. F. The fractions of cancer attributable to modifiable factors: A global review. Cancer Epidemiol. 44, 203–221 (2016).

Article  PubMed  Google Scholar 

Lewandowska, A. M., Rudzki, M., Rudzki, S., Lewandowski, T. & Laskowska, B. Environmental risk factors for cancer - review paper. Ann. Agric. Environ. Med.: AAEM 26, 1–7 (2019).

Article  CAS  PubMed  Google Scholar 

Liang, K., Liu, Q. & Kong, Q. New technologies in developing recombinant-attenuated bacteria for cancer therapy. Biotechnol. Bioeng. 118, 513–530 (2021).

Article  CAS  PubMed  Google Scholar 

Demicheli, R., Retsky, M. W., Hrushesky, W. J., Baum, M. & Gukas, I. D. The effects of surgery on tumor growth: a century of investigations. Ann. Oncol. : Off. J. Eur. Soc. Med. Oncol. 19, 1821–1828 (2008).

Article  CAS  Google Scholar 

Liu, J. et al. Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer. Bioact. Mater. 31, 315–332 (2024).

ADS  CAS  PubMed  Google Scholar 

Diakos, C. I., Charles, K. A., McMillan, D. C. & Clarke, S. J. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15, e493–e503 (2014).

Article  PubMed  Google Scholar 

Pointer, K. B., Pitroda, S. P. & Weichselbaum, R. R. Radiotherapy and immunotherapy: open questions and future strategies. Trends cancer 8, 9–20 (2022).

Article  CAS  PubMed  Google Scholar 

Hu, W., Wang, G., Huang, D., Sui, M. & Xu, Y. Cancer immunotherapy based on natural killer cells: current progress and new opportunities. Front. Immunol. 10, 1205 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun, X. et al. Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy. Nat. Nanotechnol. 16, 1260–1270 (2021).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Forbes, N. S. Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10, 785–794 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duong, M. T., Qin, Y., You, S. H. & Min, J. J. Bacteria-cancer interactions: bacteria-based cancer therapy. Exp. Mol. Med. 51, 1–15 (2019).

Article  CAS  PubMed  Google Scholar 

Siegall, C. B., FitzGerald, D. J. & Pastan, I. Selective killing of tumor cells using EGF or TGF alpha-Pseudomonas exotoxin chimeric molecules. Semin. Cancer Biol. 1, 345–350 (1990).

CAS  PubMed  Google Scholar 

Jiang, S. N. et al. Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol. Ther. J. Am. Soc. Gene Ther. 18, 635–642 (2010).

Article  CAS  Google Scholar 

St Jean, A. T., Swofford, C. A., Panteli, J. T., Brentzel, Z. J. & Forbes, N. S. Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors. Mol. Ther. J. Am. Soc. Gene Ther. 22, 1266–1274 (2014).

Article  Google Scholar 

Lehouritis, P., Springer, C. & Tangney, M. Bacterial-directed enzyme prodrug therapy. J. Control. Rel. 170, 120–131 (2013).

Article  CAS  Google Scholar 

Li, Z. et al. Chemically and biologically engineered bacteria-based delivery systems for emerging diagnosis and advanced therapy. Adv. Mater. 33, e2102580 (2021).

Article  PubMed  Google Scholar 

Deo, P. N. & Deshmukh, R. Oral microbiome: Unveiling the fundamentals. J. Oral. Maxillofac. Pathol. 23, 122–128 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Kilian, M. et al. The oral microbiome - an update for oral healthcare professionals. Br. Dent. J. 221, 657–666 (2016).

Article  CAS  PubMed  Google Scholar 

Kilian, M. The oral microbiome - friend or foe? Eur. J. Oral. Sci. 126, 5–12 (2018).

Article  PubMed  Google Scholar 

Zheng, D. W. et al. Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma. Nat. Biomed. Eng. 6, 32–43 (2022).

Article  ADS  CAS  PubMed  Google Scholar 

Karpiński, T. M. Role of oral microbiota in cancer development. Microorganisms 7, https://doi.org/10.3390/microorganisms7010020 (2019).

Laugisch, O. et al. Periodontal pathogens and associated intrathecal antibodies in early stages of Alzheimer’s disease. J. Alzheimer’s Dis. : JAD 66, 105–114 (2018).

Article  CAS  PubMed  Google Scholar 

Mesa, F. et al. Periodontitis and mechanisms of cardiometabolic risk: Novel insights and future perspectives. Biochim. Biophys. Mol. Basis Dis. 1865, 476–484 (2019).

Article  CAS  Google Scholar 

Whitmore, S. E. & Lamont, R. J. Oral bacteria and cancer. PLoS Pathog. 10, e1003933 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Drewes, J. L. et al. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. NPJ Biofilms Microbiomes 3, 34 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Yamamura, K. et al. Human Microbiome Fusobacterium Nucleatum iN Esophageal Cancer Tissue Is Associated With Prognosis. Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res. 22, 5574–5581 (2016).

Article  CAS  Google Scholar 

Katz, J., Onate, M. D., Pauley, K. M., Bhattacharyya, I. & Cha, S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int. J. Oral. Sci. 3, 209–215 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214, (2012).

Gurbatri, C. R., Arpaia, N. & Danino, T. Engineering bacteria as interactive cancer therapies. Science 378, 858–864 (2022).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Fan, J. X., Niu, M. T., Qin, Y. T., Sun, Y. X. & Zhang, X. Z. Progress of engineered bacteria for tumor therapy. Adv. Drug Deliv. Rev. 185, 114296 (2022).

Article  CAS  PubMed  Google Scholar 

Wade, W. G. The oral microbiome in health and disease. Pharmacol. Res. 69, 137–143 (2013).

Article  CAS  PubMed  Google Scholar 

Kolenbrander, P. E. Oral microbial communities: biofilms, interactions, and genetic systems. Annu. Rev. Microbiol. 54, 413–437 (2000).

Article  CAS  PubMed  Google Scholar 

Chatzigiannidou, I., Teughels, W., Van de Wiele, T. & Boon, N. Oral biofilms exposure to chlorhexidine results in altered microbial composition and metabolic profile. NPJ Biofilms Microbiomes 6, 13 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Simón-Soro, A. et al. Microbial geography of the oral cavity. J. Dent. Res. 92, 616–621 (2013).

Article  PubMed  Google Scholar 

Zijnge, V. et al. Oral biofilm architecture on natural teeth. PloS One 5, e9321 (2010).

Article  ADS  PubMed  PubMed Central  Google Scholar 

Minamino, T. & Imada, K. The bacterial flagellar motor and its structural diversity. Trends Microbiol. 23, 267–274 (2015).

Article  CAS  PubMed  Google Scholar 

Sowa, Y. et al. Direct observation of steps in rotation of the bacterial flagellar motor. Nature 437, 916–919 (2005).

Article  ADS  CAS  PubMed  Google Scholar 

Kinosita, Y., Uchida, N., Nakane, D. & Nishizaka, T. Direct observation of rotation and steps of the archaellum in the swimming halophilic archaeon Halobacterium salinarum. Nat. Microbiol. 1, 16148 (2016).

Article  CAS  PubMed